The clinical outcomes of reclassified erythroleukemia (erythroid/myeloid) as myelodysplastic syndrome (MDS) per 2017 WHO guideline compared to MDS.
Alkharabsheh O, Al-Kali A, Saadeh S, He R, Viswanatha D, Greipp P, Reichard K, Shah M, Gangat N, Patnaik M, Hogan W, Litzow M, Alkhateeb H, Nguyen PL.
Alkharabsheh O, et al. Among authors: patnaik m.
Am J Hematol. 2018 Nov;93(11):E355-E357. doi: 10.1002/ajh.25239. Epub 2018 Oct 2.
Am J Hematol. 2018.
PMID: 30074268
Free article.
No abstract available.